Alex Tessnow, MD, MBA

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Spectrix Therapeutics
    Topic:
    Thyroid hormone preparations
    Date added:
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Horizon Pharmaceuticals
    Topic:
    Thyroid eye disease
    Date added:
    03/08/2022
    Date updated:
    05/02/2024
Return to 109 Division of Hem/Onc 109 Division of Hem/Onc Solid Oncology Conference: "Thyroid Malignancies" (050924)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.